# CNO Financial Group, Inc.: financial statements, quarterly

CNO · NYSE · CIK 1224608 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cno.md) · [Financials](/companies/cno/financials.md) · [Filings](/companies/cno/filings.md) · [Insiders](/companies/cno/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cno/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [948](/filings/0001224608-25-000006.md) | [1,171](/filings/0001224608-25-000006.md) | [1,157](/filings/0001224608-26-000017.md) | [1,066](/filings/0001224608-26-000017.md) | [1,130](/filings/0001224608-26-000017.md) | [1,097](/filings/0001224608-26-000017.md) | [1,004](/filings/0001224608-26-000041.md) | [1,152](/filings/0001224608-26-000064.md) | [1,189](/filings/0001224608-26-000017.md) | [1,143](/filings/0001224608-26-000017.md) | [1,030](/filings/0001224608-26-000041.md) | [1,285](/filings/0001224608-26-000064.md) |
| Operating income | $m | [130](/filings/0001224608-24-000061.md) | [172 d](/filings/0001224608-26-000017.md) | [74.8](/filings/0001224608-25-000030.md) | [149](/filings/0001224608-25-000045.md) | [154](/filings/0001224608-25-000070.md) | [174 d](/filings/0001224608-26-000017.md) | [105](/filings/0001224608-26-000041.md) | [112](/filings/0001224608-26-000064.md) | [163](/filings/0001224608-25-000070.md) | [174 d](/filings/0001224608-26-000017.md) | [130](/filings/0001224608-26-000041.md) | [151](/filings/0001224608-26-000064.md) |
| Interest expense | $m | [62.6](/filings/0001224608-24-000061.md) | [63.7 d](/filings/0001224608-26-000017.md) | [60.2](/filings/0001224608-25-000030.md) | [64.2](/filings/0001224608-25-000045.md) | [68.0](/filings/0001224608-25-000070.md) | [62.0 d](/filings/0001224608-26-000017.md) | [62.0](/filings/0001224608-26-000041.md) | [59.1](/filings/0001224608-26-000064.md) | [56.6](/filings/0001224608-25-000070.md) | [53.2 d](/filings/0001224608-26-000017.md) | [50.9](/filings/0001224608-26-000041.md) | [55.3](/filings/0001224608-26-000064.md) |
| Income tax | $m | [48.3](/filings/0001224608-25-000006.md) | [9.8](/filings/0001224608-25-000006.md) | [33.9](/filings/0001224608-25-000030.md) | [34.3](/filings/0001224608-25-000045.md) | [1.7](/filings/0001224608-25-000070.md) | [44.4](/filings/0001224608-25-000006.md) | [6.3](/filings/0001224608-26-000041.md) | [26.2](/filings/0001224608-26-000064.md) | [28.2](/filings/0001224608-25-000070.md) | [3.4 d](/filings/0001224608-26-000017.md) | [10.7](/filings/0001224608-26-000041.md) | [33.8](/filings/0001224608-26-000064.md) |
| Net income | $m | [167](/filings/0001224608-25-000006.md) | [36.3](/filings/0001224608-25-000006.md) | [112](/filings/0001224608-26-000017.md) | [116](/filings/0001224608-26-000017.md) | [9.3](/filings/0001224608-26-000017.md) | [183](/filings/0001224608-26-000017.md) | [21.5](/filings/0001224608-26-000041.md) | [91.8](/filings/0001224608-26-000064.md) | [23.1](/filings/0001224608-26-000017.md) | [92.9](/filings/0001224608-26-000017.md) | [37.7](/filings/0001224608-26-000041.md) | [126](/filings/0001224608-26-000064.md) |
| Diluted EPS | $ per share | [1.46](/filings/0001224608-25-000006.md) | [0.32](/filings/0001224608-25-000006.md) | [1.01](/filings/0001224608-26-000017.md) | [1.06](/filings/0001224608-26-000017.md) | [0.09](/filings/0001224608-26-000017.md) | [1.74](/filings/0001224608-26-000017.md) | [0.21](/filings/0001224608-26-000041.md) | [0.91](/filings/0001224608-26-000064.md) | [0.24](/filings/0001224608-26-000017.md) | [0.95](/filings/0001224608-26-000017.md) | [0.39](/filings/0001224608-26-000041.md) | [1.33](/filings/0001224608-26-000064.md) |
| Basic EPS | $ per share | [1.48](/filings/0001224608-25-000006.md) | [0.33](/filings/0001224608-25-000006.md) | [1.03](/filings/0001224608-26-000017.md) | [1.08](/filings/0001224608-26-000017.md) | [0.09](/filings/0001224608-26-000017.md) | [1.78](/filings/0001224608-26-000017.md) | [0.21](/filings/0001224608-26-000041.md) | [0.93](/filings/0001224608-26-000064.md) | [0.24](/filings/0001224608-26-000017.md) | [0.98](/filings/0001224608-26-000017.md) | [0.40](/filings/0001224608-26-000041.md) | [1.35](/filings/0001224608-26-000064.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [33.5](/filings/0001224608-23-000061.md) | [35.0](/filings/0001224608-25-000006.md) | [34.9](/filings/0001224608-24-000041.md) | [36.3](/filings/0001224608-24-000050.md) | [37.6](/filings/0001224608-24-000061.md) | [37.8](/filings/0001224608-26-000017.md) | [37.4](/filings/0001224608-25-000030.md) | [37.3](/filings/0001224608-25-000045.md) | [38.3](/filings/0001224608-25-000070.md) | [38.8](/filings/0001224608-26-000064.md) | [39.0](/filings/0001224608-26-000041.md) | [39.9](/filings/0001224608-26-000064.md) |
| Total liabilities | $bn | [31.6](/filings/0001224608-23-000061.md) | [32.8](/filings/0001224608-25-000006.md) | [32.6](/filings/0001224608-24-000041.md) | [33.9](/filings/0001224608-24-000050.md) | [35.0](/filings/0001224608-24-000061.md) | [35.3](/filings/0001224608-26-000017.md) | [34.9](/filings/0001224608-25-000030.md) | [34.8](/filings/0001224608-25-000045.md) | [35.7](/filings/0001224608-25-000070.md) | [36.2](/filings/0001224608-26-000064.md) | [36.5](/filings/0001224608-26-000041.md) | [37.3](/filings/0001224608-26-000064.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [1.9](/filings/0001224608-24-000061.md) | [2.2](/filings/0001224608-26-000017.md) | [2.4](/filings/0001224608-25-000045.md) | [2.4](/filings/0001224608-25-000070.md) | [2.7](/filings/0001224608-25-000070.md) | [2.5](/filings/0001224608-26-000064.md) | [2.6](/filings/0001224608-26-000064.md) | [2.5](/filings/0001224608-26-000064.md) | [2.6](/filings/0001224608-25-000070.md) | [2.6](/filings/0001224608-26-000064.md) | [2.5](/filings/0001224608-26-000064.md) | [2.6](/filings/0001224608-26-000064.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [183 d](/filings/0001224608-24-000061.md) | [177 d](/filings/0001224608-26-000017.md) | [94.6](/filings/0001224608-25-000030.md) | [111 d](/filings/0001224608-25-000045.md) | [231 d](/filings/0001224608-25-000070.md) | [191 d](/filings/0001224608-26-000017.md) | [137](/filings/0001224608-26-000041.md) | [146 d](/filings/0001224608-26-000064.md) | [198 d](/filings/0001224608-25-000070.md) | [196 d](/filings/0001224608-26-000017.md) | [149](/filings/0001224608-26-000041.md) | [157 d](/filings/0001224608-26-000064.md) |
| Dividends paid | $m | [16.9 d](/filings/0001224608-24-000061.md) | [16.7 d](/filings/0001224608-26-000017.md) | [17.3](/filings/0001224608-25-000030.md) | [17.2 d](/filings/0001224608-25-000045.md) | [16.8 d](/filings/0001224608-25-000070.md) | [16.4 d](/filings/0001224608-26-000017.md) | [16.9](/filings/0001224608-26-000041.md) | [16.7 d](/filings/0001224608-26-000064.md) | [16.4 d](/filings/0001224608-25-000070.md) | [16.2 d](/filings/0001224608-26-000017.md) | [17.1](/filings/0001224608-26-000041.md) | [16.7 d](/filings/0001224608-26-000064.md) |
| Share repurchases | $m | [40.2 d](/filings/0001224608-24-000061.md) | [70.3 d](/filings/0001224608-26-000017.md) | [58.8](/filings/0001224608-25-000030.md) | [59.8 d](/filings/0001224608-25-000045.md) | [89.9 d](/filings/0001224608-25-000070.md) | [91.7 d](/filings/0001224608-26-000017.md) | [110](/filings/0001224608-26-000041.md) | [100 d](/filings/0001224608-26-000064.md) | [60.6 d](/filings/0001224608-25-000070.md) | [60.2 d](/filings/0001224608-26-000017.md) | [73.3](/filings/0001224608-26-000041.md) | [60.9 d](/filings/0001224608-26-000064.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [116](/filings/0001224608-23-000061.md) | [115](/filings/0001224608-24-000041.md) | [116](/filings/0001224608-24-000050.md) | [114](/filings/0001224608-24-000061.md) | [111](/filings/0001224608-25-000030.md) | [109](/filings/0001224608-25-000045.md) | [107](/filings/0001224608-25-000070.md) | [103](/filings/0001224608-26-000041.md) | [100](/filings/0001224608-26-000064.md) | [98.6](/filings/0001224608-25-000070.md) | [96.1](/filings/0001224608-26-000041.md) | [95.0](/filings/0001224608-26-000064.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 92,521,371 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001224608-26-000064.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.